FORM 10-Q/A
Amendment to submit:
(1) Part II
(2) Signature Page
(3) Exhibit 27 - Financial Data Schedule
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Quarterly Report Under Section 13 or 15(d)
of the Securities Exchange Act of 1934
For Quarter Ended
July 31, 1995 Commission File No. 0-17174
HAUSER CHEMICAL RESEARCH, INC.
Delaware 84-0926801
(State or other jurisdiction (I.R.S. Identification
Number)
of incorporation or organization)
5555 Airport Boulevard, Boulder, Colorado 80301
(Address of principal executive offices) (Zip Code)
Registrant's telephone number,
including area code: (303) 443-4662
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.
Common Stock, $ .001 par value 10,539,668
Class Outstanding at July 31, 1995
<PAGE>
Part II
Item 1 Legal Proceedings
None
Item 2 Changes in Securities
None
Item 3 Defaults Upon Senior Securities
None
Item 4 Submission of Matters to a Vote of Security Holders
None
Item 5 Other Information
None
Item 6 Exhibits and Reports on Form 8-K
(a) Exhibits -- Exhibit 27 Financial Data Schedule
for 3-MOS. ended July 31, 1995.
(b) No reports on Form 8-K have been filed during
the quarter ended July 31, 1995.
<PAGE>
FORM 10-Q
SIGNATURES
Persuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
HAUSER CHEMICAL RESEARCH, INC.
Date: September 12, 1995 /Dean P. Stull
Dean P. Stull, Chairman of the Board, CEO,
and President
Date: September 12, 1995 /William E. Paukert
William E. Paukert, Chief Financial Officer,
and Treasurer
<PAGE>
FORM 10-Q/A
SIGNATURES
Persuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
HAUSER CHEMICAL RESEARCH, INC.
Date: November 9, 1995 /Dean P. Stull
Dean P. Stull, Chairman of the Board, CEO,
and President
Date: November 9, 1995 /William E. Paukert
William E. Paukert, Chief Financial Officer,
and Treasurer
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S 1ST QUARTER 10-Q FOR FISCAL 1996 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> APR-30-1996
<PERIOD-END> JUL-31-1995
<CASH> 3,812,177
<SECURITIES> 16,944,663
<RECEIVABLES> 5,655,693
<ALLOWANCES> 299,850
<INVENTORY> 6,330,217<F1>
<CURRENT-ASSETS> 36,714,056
<PP&E> 39,112,316
<DEPRECIATION> 12,487,293
<TOTAL-ASSETS> 81,878,115
<CURRENT-LIABILITIES> 3,330,547
<BONDS> 68,825
<COMMON> 10,540
0
0
<OTHER-SE> 75,542,085
<TOTAL-LIABILITY-AND-EQUITY> 81,878,115
<SALES> 2,444,352
<TOTAL-REVENUES> 4,034,174
<CGS> 4,746,407
<TOTAL-COSTS> 4,746,407
<OTHER-EXPENSES> 2,346,422
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 6,411
<INCOME-PRETAX> (2,714,485)
<INCOME-TAX> (950,150)
<INCOME-CONTINUING> (1,764,335)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,764,335)
<EPS-PRIMARY> (.17)
<EPS-DILUTED> (.17)
<FN>
<F1>EXCLUDES 9,521,717 OF LONG-TERM INVENTORY
</FN>
</TABLE>
